SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Front Street Capital Management, Inc. | 24,000 | $21 | 0.01% |
| Keystone Financial Group | 24,700 | $21,884 | 0.00% |
| Csenge Advisory Group | 51,456 | $45,590 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $17,720 | 0.00% |
| M&T BANK CORP | 41,852 | $1,815,022 | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 1,657,557 | $1,468,596 | 0.00% |
| Newbridge Financial Services Group, Inc. | 6,650 | $5,892 | 0.00% |
| Moors & Cabot, Inc. | 56,500 | $50,059 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 40,255 | $36 | 0.00% |
| STATE STREET CORP | 101,275,142 | $89,729,776 | 0.00% |
| J.W. COLE ADVISORS, INC. | 43,200 | $38,275 | 0.00% |
| Larson Financial Group LLC | 15,825 | $14,021 | 0.00% |
| IFG Advisory, LLC | 20,000 | $17 | 0.00% |
| Squarepoint Ops LLC | 627,926 | $556,342 | 0.00% |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 243,451 | $215,698 | 0.00% |
| NorthRock Partners, LLC | 19,055 | $16,883 | 0.00% |
| Crescent Grove Advisors, LLC | 22,000 | $19,492 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $3 | 0.00% |
| Ameritas Investment Partners, Inc. | 36,911 | $39,495 | 0.00% |
| AXA S.A. | 774,200 | $685,941 | 0.00% |
External links
This page lists SORRENTO THERAPEUTICS INC's shareholders in Q4 2022. To view SORRENTO THERAPEUTICS INC's shareholder history, click here.